OneSource Speci. — 360° view

OneSource Speci, a company in the Pharmaceuticals industry, reported revenue of ₹516 crore and net profit of ₹57 crore for the September 2026 quarter.

OneSource Speci. (NSE: ONESOURCE) closed at ₹1,609.30 on 20 Nov 2026, down 3.8% over the past year. Its market capitalisation is ₹18,455 crore and it trades at 1613.2 times earnings.

Share price
₹1,609.30 (20 Nov 2026)
Market cap
₹18,455 Cr (20 Nov 2026)
P/E
1613.16 (20 Nov 2026)
Revenue
₹516 Cr (September 2026 quarter)
Net profit
₹57 Cr (September 2026 quarter)
ROCE
0.59% (FY26)
ROE
-1.09% (FY26)
Book value
₹516 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹1,917.80 / ₹1,057.00 (20 Nov 2026)
1-year return
-3.8% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: ONESOURCE

Incorporated in 2007, OneSource Specialty Pharma Ltd is in the research, development, manufacture and commercialisation of bio logical drug products in various injectable formats. It also offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.